Cargando…
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis
Background: Interleukin-6 (IL-6) is known to be detrimental in coronavirus disease 2019 (COVID-19) because of its involvement in driving cytokine storm. This systematic review and meta-analysis aimed to assess the safety and efficacy of anti-IL-6 signaling (anti-IL6/IL-6R/JAK) agents on COVID-19 bas...
Autores principales: | Han, Qi, Guo, Mingyue, Zheng, Yue, Zhang, Ying, De, Yanshan, Xu, Changchang, Zhang, Lin, Sun, Ruru, Lv, Ying, Liang, Yan, Xu, Feng, Pang, Jiaojiao, Chen, Yuguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769953/ https://www.ncbi.nlm.nih.gov/pubmed/33384605 http://dx.doi.org/10.3389/fphar.2020.615972 |
Ejemplares similares
-
ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock
por: Zhang, Ying, et al.
Publicado: (2023) -
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants
por: Guo, Mingyue, et al.
Publicado: (2022) -
Role of the circulatory interleukin-6 in the pathogenesis of gliomas: A systematic review
por: Singh, Manish, et al.
Publicado: (2022) -
Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022) -
Role of Interleukin-6 and Its Receptor in Endometriosis
por: Li, Shihui, et al.
Publicado: (2017)